Monoclonal Anti- Sulfamerazine / Sulfaguanidine Antibody
Size: 1mg
Host: Mouse
Purification & Buffer: Protein A or G purified and supplied in 0.01 M PBS (pH7.4)
Purity: >95% by HPLC & SDS-PAGE
Application: ELISA
--------------------------------------------------------------------------------------------------------------
Price: $685.00
Catalog# BDA1019
Lot # Check on the product label
Size 1mg
Host Mouse
Product Form Liquid
Concentration 8 mg/ml (Changed for different lots)
Purification & Buffer
Protein A or G purified and supplied in 0.01 M PBS (pH7.4)
Purity >95% by HPLC & SDS-PAGE
IC50 Value
0.6-1.0 ppb
Sensitivity 4 ppb
Recommend Application
ELISA (1:100000)
Other applications have not been tested.
The optimal dilutions should be determined by end user.
Storage Instruction
Aliquot and store at -20°C for 2 years.
Avoid repeated freeze and thaw cycles.
Background
Aloisio C et al investigated the effect on solubility and release of ternary complexes of sulfamerazine (SMR) with β-(βCD), methyl-(MβCD) and hydroxypropyl-β-cyclodextrin (HPβCD) using meglumine (MEG) as the ternary component. Solid state analysis was performed using Fourier-transform infrared spectroscopy (FT IR), differential scanning calorimetry (DSC) and powder X-ray diffraction (XRD), which demonstrated that different interactions occurred among SMR, MEG and MβCD or HPβCD in the ternary lyophilized systems. The ternary complexes with βCD and MβCD produced an additional retention effect on the release of SMR compared to the corresponding binary complexes, implying that they were clearly superior in terms of solubility and release modulation.
Reference
1. Aloisio C, de Oliveira AG, Longhi M. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine. J Pharm Biomed Anal. 2014 Nov;100:64-73.